of the Danish biotech company Danisco, and BRAIN, an European industrial biotech company, join forces in the field of the biobased fermentative production of industrially relevant biochemicals from renewable raw materials.
its extensive capabilities in metabolic pathway engineering and bio-manufacturing of industrial bio-products and BRAIN’s world leading expertise in the fields of metagenomics and screening technologies, to pursue product targets for the chemical industry.
Genencor access to these technologies and especially to its vast metagenome resources of some 150 million genes of yet uncultured microorganisms. Enzymes and biosynthetic pathways of interest will then be genetically engineered in microbial production strains for the production of important biochemicals. The products can replace petrochemicals and be used in e.g. biofuels, plastics, rubber, adhesives and cosmetics.
announced today expands upon the successful collaboration first established in 2004, where the two companies joined forces to develop a new enzyme product platform.
is also an important milestone in the company’s strategy of further expanding its strategic partnerships with globally successful partners from the biochemical industry, thereby strengthening the industrial network at its disposal and ensuring increased support for future projects.
BREAKING